Objective-To determine the policy and practice of district health authorities in England and Wales for BCG immunisation in schoolchildren and neonates.
Introduction
Although the overall number of tuberculosis notifications has remained about the same since the mid1980s,' the overall incidence of tuberculosis has been declining in England and Wales for at least 100 years.2 Specific chemotherapy since the 1940s and BCG immunisation of schoolchildiren since the 1950s and, more recently, of neonates in high risk groups may have contributed to the decline in recent decades. As the incidence of disease has dropped to low levels, so the potential for preventing new cases of tuberculosis by the schools BCG immunisation programme has diminished.3 In addition, giving BCG vaccine to neonates in high risk groups means that many of the most vulnerable children are already protected by the time they are eligible for the schools programme. 4 In 1983 a survey of BCG immunisation policies for schoolchildren and neonates in health districts of England and Wales revealed that five health authorities had discontinued their schools programme and a further 10 had their policy under review. 5 The national survey of notifications of tuberculosis, also in 1983, confirmed the continuing fall in notification rates in the white population.6 Similar rates of decline were also seen in people originating from the Indian subcontinent, but the rates in this group were still 20-30 times higher than those in the indigenous population. After reviewing these data in 1985 the Joint Committee on Vaccination and Immunisation recommended the continuation of the schools programme, with the intention of stopping by 1990 provided that a further notification survey showed that the downward trend in notifications was maintained. 7 Despite a continuing decline in the age and sex specific incidence of tuberculosis up to 1987, small increases in the total number of notifications were observed in 1988 and 1989. 8 Contrary to expectations, the in supply of BCG vaccine in 1989 was factor in stopping the schools prog page was most often related to the tuberculosis locally. Districts not a programme were most often locate south western England and had popu proportion of residents of Indian sut One district that discontinued its sc in 1981 concluded that the change policy did not affect the continuat decline in notifications, although foll cases and deaths notified from that r include cases that might have been notified elsewhere. '3 The Heaf tuberculin test remains the most used of the available methods and seems to be associated with few problems. A new gun with a disposable magnetic head, which has been developed under the guidance of the Department of Health, is now available for general use and will make the use of the Heaf test easier and avoid any risk of cross infection.
ACTION ON TEST RESULTS
The variation in the actions carried out in response to tuberculin test results in school children indicates the lack of clarity in published guidance. Ninety seven ine was given to districts (57%) recommend that children with a grade 2 with needle and result and with no history of BCG immunisation be itaneous multiple referred to a chest clinic. As a result, however, of the as carried out. No low true prevalence of this infection in schoolchildren eported.
in For neonates there has been an encouraging increase J immunisation of in the number of districts offering selective immunisaealth districts in tion. However, it is of concern that 31 districts do not is of concern that offer BCG to any group of newborn children, particuIs programme and larly as eight of these districts estimated that they had f neonates.
populations of Indian subcontinent origin greater had been stopped than 3%. BCG immunisation of neonates has been one of these the shown to be effective in protecting children of e programme was Indian subcontinent origin against tuberculosis in 11 more districts England.' 5'7 ogramme and 13 A recent study from Leeds suggested that poverty, vever, none of the as indicated by residence in a "designated urban ter review in 1983 priority area," was an important indicator of the risk of ame by 1991. tuberculosis in children. The study's authors advoterruption in the cated that selective BCG policies for neonates should not an important not depend on ethnic group alone,'8 and it is interesting rammne; the stop-to note that seven districts stated that they offer BCG Tuberculin testing of neonates is less common than testing of schoolchildren, but it is surprising that in five districts no action was recommended for grade 2 results in this age group. Indeed in neonates even a grade 1 result should be considered with suspicion, especially if there is any recent history of contact with tuberculosis.
Whoever takes the leading role in devising a district's policy for BCG immunisation, it is appropriate that the consultant in communicable disease control (or other public health physician, if a consultant is not in post) as well as the district immunisation coordinator consult with a chest physician (or physician with an interest in respiratory medicine) about the policy for the schools programme and with a paediatrician on the policy for the programme in neonates. In addition, it would seem prudent to have such policies reviewed by either a district control of infection committee or an immunisation comnuittee.
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